Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Garry Menzel Insider Profile
4 Followers
Garry Menzel, President & CEO, Director at TCR2 Therapeutics, holds 0.00 shares in TCR2 Therapeutics (Ticker: TCRR), holds 51.83K shares in Black Diamond Therapeutics (Ticker: BDTX), holds ― shares in Stoke Therapeutics (Ticker: STOK).
Garry Menzel TCR2 Therapeutics (TCRR)President & CEO, Director
TCR2 Therapeutics (TCRR)
President & CEO, Director
Not Ranked
Garry Menzel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Garry Menzel holds in companies
Most Profitable Insider Trade
Stock:
TCR2 Therapeutics
(TCRR)
(TCRR)
Rating:Informative Buy
Date:Dec 10, 2021 - Dec 10, 2022
Return:-77.00%
The most profitable trade made by Garry Menzel
Garry Menzel's Trading History
TCR2 Therapeutics
Jun 01, 2023
―
Uninformative Sell
―
$0.00
Black Diamond Therapeutics
Feb 05, 2020
Director
Uninformative Buy
―
$305.25K
Stoke Therapeutics
―
Director
―
―
Adaptimmune Therapeutics
Jul 10, 2023
Director
Uninformative Sell
43.41K
$80.69K
Regulus
Oct 04, 2012
COO & Executive VP, Finance
Uninformative Buy
―
$270.66K
DaVita
―
SVP Finance
―
$0.00
List of latest transactions for each holding click on a transaction to see Garry Menzel's performance on stock
You May Also Like
Garry Menzel insider profile FAQ
What is the percentage of profitable transactions made by Garry Menzel?
The percentage of profitable transactions made by Garry Menzel is ―.
What is the average return per transaction made by Garry Menzel?
The average return per transaction made by Garry Menzel is ―.
What stocks does Garry Menzel hold?
Garry Menzel holds: TCRR, BDTX, STOK, ADAP, RGLS, DVA stocks.
What was Garry Menzel’s latest transaction?
Garry Menzel latest transaction was an Uninformative Sell of ―.
What was Garry Menzel's most profitable transaction?
Garry Menzel’s most profitable transaction was an Informative Buy of TCRR stock on December 10, 2021. The return on the trade was -77.00%.
What is Garry Menzel's role in TCR2 Therapeutics?
Garry Menzel's role in TCR2 Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.